In the HER2-positive gastric tumors, the expression status of both p-Smad2 and c-Met was positive in both the primary tumor and metastatic lymph nodes, and the p-Smad2 and c-Met expression levels in the metastatic lymph nodes tended to be higher than those in the primary tumors. Here, ERBB2 is linked to gastric neoplasm.